Recollect the Game: A Novel Treatment for Executive Functioning Deficits in Adults With ADHD
1 other identifier
interventional
40
1 country
1
Brief Summary
Adults who have attention deficit hyperactivity disorder (ADHD) suffer from significant occupational, academic and social problems, many of which are believed to be a result of problems with executive functioning. Executive functioning refers to a group of neuro-psychological functions which include sustained attention, working memory, verbal fluency, as well as motor and mental processing speed. Individuals with ADHD have been shown to have deficits in executive functioning independent of IQ, co-occurring psychiatric disorders, gender, and ADHD subtype. "Recollect" is an application (App) based working memory training video game where participants conduct 3-different adaptive working memory tasks. In each of these tasks participants are presented with a set of stimuli to be remembered while playing a simple platform game where they help navigate an astronaut across the screen and dodge obstacles. Recollect has been designed for all age groups to an interesting, fun and effective brain-training activity. The memory tasks included in the game have been independently shown to improve working memory in a manner that transfers to untrained tasks. The purpose of this study is to evaluate the effects of playing Recollect versus Tetris for 20 minutes per day, 5 days per week over a 4 week period, on executive functioning deficits in individuals who have Adult ADHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2018
CompletedFirst Posted
Study publicly available on registry
February 19, 2018
CompletedStudy Start
First participant enrolled
March 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedOctober 26, 2023
October 1, 2023
5.8 years
February 7, 2018
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline on The Behavioral Rating Inventory of Executive Functioning - Adult Version (BRIEF-A)
It is a validated, clinician-rated scale, measuring executive functioning. The scale includes 75 items that rates patient symptoms on a 3-point Likert scale (1 = behavior is never observed to 3 = behavior is often observed). Scores range from 75 to 225: Higher scores indicate greater impairment in executive functioning.
Change from baseline to week 4
Secondary Outcomes (2)
Change from baseline on the Barkley Adult ADHD Rating Scale (BAARS-IV)
Change from baseline to week 4
Change from baseline on an App-based neuro-cognitive battery
Change from baseline to week 4
Study Arms (2)
Recollect
EXPERIMENTALRecollect is a video game which incorporates scientifically supported renditions of N-Back, Item Span, and Multiple-Identity tracking tasks. These tasks are independently shown to improve working memory in a manner that transfers to untrained tasks.
Tetris
SHAM COMPARATORTetris is a video game which has not been shown to have any benefits in the improvement of executive functioning.
Interventions
Eligibility Criteria
You may qualify if:
- Males and females aged 18 and older who own a mobile device such as a Smartphone or tablet.
- Current diagnosis of Adult ADHD, at any stage of treatment.
- Comorbid psychiatric conditions will be allowed.
- Medication or psychotherapy must have been stable (no dose changes) for 4 weeks prior to study participation.
- Must be able to read, write and understand English.
You may not qualify if:
- Participant does not own a Smartphone or tablet.
- No dose changes during the 4 week study period.
- No initiation of new psychological therapy or counselling during the 4 week study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MacAnxiety Research Centre
Hamilton, Ontario, L8S 1B7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Van Ameringen, MD, FRCPC
McMaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2018
First Posted
February 19, 2018
Study Start
March 14, 2019
Primary Completion
December 31, 2024
Study Completion
February 28, 2025
Last Updated
October 26, 2023
Record last verified: 2023-10